Agenzia Italiana del Farmaco
Direct communication with healthcare professionals on Voxzogo®️ (vosoritide) - Direct communication with healthcare professionals on Voxzogo®️ (vosoritide)
Direct communication with healthcare professionals on Voxzogo®️ (vosoritide)
Voxzogo® (vosoritide): change to administration syringe and needle leading to product administration in Units (U) instead of mL.
Summary
- From July 2023, Voxzogo co-packs will contain new solvent needles and new administration syringes due to supply chain reasons.
- The new solvent needle has an alternative safety mechanism with an activated safety shield cover (see Table 1).
- The new administration syringe has Units (U) graduation markings( typically used for insulin products and sometimes referred to as Insulin Units) instead of mL graduation markings (see Table 1).
- It is important that you explain to your patient or the caregiver the recommended dose to be delivered with the new syringe, as the units of measure are not 1:1. For example, 0.1 mL is equivalent to 10 U. Please see Table 2 for the conversion of single dose volumes from mL to U.
- There are no changes to the Voxzogo dosage or volume. Recommendations for use remain unchanged.
- The product information has been amended to reflect the use of new needles and syringes.
Published on: 04 September 2023
📢 Fibrosi cistica: #AIFA amplia l’accesso gratuito ai nuovi #farmaci modulatori di CFTR
👉 Tutti i ...
Vai al post →
🤝 “Patto di solidarietà per la vita”
📍 Il Direttore Amministrativo #AIFA Giovanni Pavesi all’even...
Vai al post →
📊 Online “OsMed interattivo”, la piattaforma aggiornata con i dati più recenti su consumi e spesa d...
Vai al post →
Ogni anno il Rapporto OsMed offre una fotografia aggiornata dell’uso dei #farmaci in Italia.
Un ins...
Vai al post →
“Se non sei un medico, non fare il medico.”
Uno slogan semplice, ma che nasce da un problema ancora ...
Vai al post →
🗞️ Oggi a Milano una giornata significativa per l’Agenzia Italiana del Farmaco: per la prima volta ...
Vai al post →
